What is the equity of Vaxart this year?
Vaxart has equity of 57.81 M USD this year.
Vaxart Equity 2024
Vaxart Equity
57.81 M USD
Ticker
VXRT
ISIN
US92243A2006
WKN
A2JD8X
In 2024, Vaxart's equity was 57.81 M USD, a -47.74% increase from the 110.6 M USD equity in the previous year.
Vaxart Aktienanalyse
What does Vaxart do?
Vaxart Inc is a US biotechnology company that was founded in 2004 and is based in South San Francisco, California. The company specializes in the development of oral vaccines and therapeutics. Vaxart ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Vaxart's Equity
Vaxart's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Vaxart's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Vaxart's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Vaxart's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Vaxart’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Vaxart stock
What was the equity of Vaxart compared to the previous year?
The equity of Vaxart has increased/decreased by -47.74% decreased compared to the previous year.
What impact does a high equity have on investors of Vaxart?
A high equity is advantageous for investors of Vaxart as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Vaxart?
A low equity can be a risk for investors of Vaxart, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Vaxart affect the company?
An increase in equity of Vaxart can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Vaxart affect the company?
A reduction in equity of Vaxart can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Vaxart?
Some factors that can affect the equity of Vaxart include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Vaxart so important for investors?
The equity of Vaxart is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Vaxart take to change the equity?
To change equity, Vaxart can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Vaxart pay?
Over the past 12 months, Vaxart paid a dividend of 73.13 USD . This corresponds to a dividend yield of about 10,121.52 %. For the coming 12 months, Vaxart is expected to pay a dividend of 0 USD.
What is the dividend yield of Vaxart?
The current dividend yield of Vaxart is 10,121.52 %.
When does Vaxart pay dividends?
Vaxart pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Vaxart?
Vaxart paid dividends every year for the past 0 years.
What is the dividend of Vaxart?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Vaxart located?
Vaxart is assigned to the 'Health' sector.
Wann musste ich die Aktien von Vaxart kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Vaxart from 11/8/2012 amounting to 6.648 USD, you needed to have the stock in your portfolio before the ex-date on 11/9/2012.
When did Vaxart pay the last dividend?
The last dividend was paid out on 11/8/2012.
What was the dividend of Vaxart in the year 2023?
In the year 2023, Vaxart distributed 0 USD as dividends.
In which currency does Vaxart pay out the dividend?
The dividends of Vaxart are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Vaxart
Our stock analysis for Vaxart Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Vaxart Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
